A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

Clinical trial NCT04981431 · COMPLETED

Trial details

NCT number: NCT04981431
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Start date: 2021-08-11
Primary completion: 2022-03-13
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.